These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24431836)

  • 21. Botulinum toxin for the correction of hyperkinetic facial lines.
    Goodman G
    Australas J Dermatol; 1998 Aug; 39(3):158-63. PubMed ID: 9737041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females.
    Carruthers A; Carruthers J; Said S
    Dermatol Surg; 2005 Apr; 31(4):414-22; discussion 422. PubMed ID: 15871316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exaggeration of wrinkles after botulinum toxin injection for forehead horizontal lines.
    Kang SM; Feneran A; Kim JK; Park O; Kim JE; Won CH; Chang S; Lee MW; Choi JH; Moon KC; Youn CS; Cho S; Lee SH
    Ann Dermatol; 2011 May; 23(2):217-21. PubMed ID: 21747624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A.
    Chang SP; Tsai HH; Chen WY; Lee WR; Chen PL; Tsai TH
    Int J Dermatol; 2008 Dec; 47(12):1287-94. PubMed ID: 19126019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Botulinum toxin in the treatment of frontoglabellar and periorbital wrinkles. An initial study].
    Ascher B; Klap P; Marion MH; Chanteloub F
    Ann Chir Plast Esthet; 1995 Feb; 40(1):67-76. PubMed ID: 7668808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel, volumizing cosmetic formulation significantly improves the appearance of target Glabellar lines, nasolabial folds, and crow's feet in a double-blind, vehicle-controlled clinical trial.
    Farris PK; Edison BL; Weinkauf RL; Green BA
    J Drugs Dermatol; 2014 Jan; 13(1):41-6. PubMed ID: 24385118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermal and epidermal remodeling using botulinum toxin type A for facial, non reducible, hyperkinetic lines: two case studies.
    Bowler PJ
    J Cosmet Dermatol; 2008 Sep; 7(3):241-4. PubMed ID: 18789065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Prabotulinumtoxin A and Onabotulinumtoxin A for Crow's Feet: A Phase 3, Multicenter, Randomized, Double-Blind, Split-Face Study.
    Cheon HI; Jung N; Won CH; Kim BJ; Lee YW
    Dermatol Surg; 2019 Dec; 45(12):1610-1619. PubMed ID: 30893169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
    Farahvash MR; Arad S
    J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abobotulinum toxin A for periorbital facial rejuvenation: impact on ocular refractive parameters.
    Eftekhari MH; Aghaei H; Kangari H; Bahrami M; Eftekhari S; Tabatabaee SM; Shahraki K; Bahrami M; Broumand MG
    Clin Exp Optom; 2021 Jan; 104(1):115-118. PubMed ID: 32783216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemodenervation for facial dystonias and wrinkles.
    Harrison AR
    Curr Opin Ophthalmol; 2003 Oct; 14(5):241-5. PubMed ID: 14502050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis.
    Yamauchi PS; Lowe NJ
    Clin Dermatol; 2004; 22(1):34-9. PubMed ID: 15158543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum A toxin (BOTOX) in the lower eyelid: dose-finding study.
    Flynn TC; Carruthers JA; Carruthers JA; Clark RE
    Dermatol Surg; 2003 Sep; 29(9):943-50; discussion 950-1. PubMed ID: 12930337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triple-Blind, Prospective, Internally Controlled Comparative Study Between AbobotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Facial Rhytids.
    Kassir R; Kolluru A; Kassir M
    Dermatol Ther (Heidelb); 2013 Dec; 3(2):179-89. PubMed ID: 24318416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin for the treatment of hyperfunctional lines of the forehead.
    Sunil SM; Babu BG; Deepthi S; Veerabhadrappa AC; Vadavadagi SV; Punde P
    J Int Soc Prev Community Dent; 2015; 5(4):276-82. PubMed ID: 26312226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reproducibility of two four-point clinical severity scores for lateral canthal lines (crow's feet).
    Hund T; Ascher B; Rzany B;
    Dermatol Surg; 2006 Oct; 32(10):1256-60. PubMed ID: 17034375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of botulinum toxin type A (Botox) on facial lines: a comparison in identical twins.
    Binder WJ
    Arch Facial Plast Surg; 2006; 8(6):426-31. PubMed ID: 17116793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin A: a 9-month clinical and 3D in vivo profilometric crow's feet wrinkle formation study.
    Levy JL; Servant JJ; Jouve E
    J Cosmet Laser Ther; 2004 May; 6(1):16-20. PubMed ID: 15370408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum A toxin for glabellar wrinkles. Dose and response.
    Hankins CL; Strimling R; Rogers GS
    Dermatol Surg; 1998 Nov; 24(11):1181-3. PubMed ID: 9834736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.